Cancer Research Landon Prizes for Basic and Translational Cancer Research  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 51, 6385-6387, December 1, 1991]
© 1991 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Law, J. C.
Right arrow Articles by Ferrell, R. E.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Law, J. C.
Right arrow Articles by Ferrell, R. E.

A Germ Line Mutation in Exon 5 of the p53 Gene in an Extended Cancer Family1

John C. Law, Louise C. Strong, Abirami Chidambaram and Robert E. Ferrell2

Department of Human Genetics, Graduate School of Public Health, and Pittsburgh Cancer Institute, University of Pittsburgh, Pittsburgh, Pennsylvania 15261 [J. C. L., R. E. F.], and Division of Pediatrics [L. C. S.] and Department of Molecular Genetics [A. C.], University of Texas, M. D. Anderson Cancer Center, Houston, Texas 77030

Germ line p53 point mutations have been reported for some families with Li-Fraumeni syndrome, a syndrome characterized by a dominantly inherited increased susceptibility for the development of early age of onset neoplasms of diverse origin in multiple family members. All of the initially reported p53 germ line mutations have been found exclusively within a single conserved, nonpolymorphic region of the gene between condons 245 and 258. The restricted distribution of these inherited mutations has led to speculation that germ line p53 mutations have unique properties [B. Vogelstein, Nature (Lond.), 348: 681–682, 1990]. We report here on the identification of a p53 germ line mutation at codon 133 (ATG -> ACG) in nine members of an extended Li-Fraumeni syndrome family. This mutation leads to an amino acid substitution in the protein and is shown to completely cosegregate with Li-Fraumeni syndrome associated cancer in this family. Its location extends the region of the p53 gene where inherited mutations predisposing to cancer are observed and suggests that their distribution may be diverse.

1 This work was supported by NIH Grant CA34936.

2 To whom requests for reprints should be addressed.

Received 8/28/91. Accepted 10/10/91.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1991 by the American Association for Cancer Research.